Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

Bibliographic Details
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/?tool=EBI
_version_ 1828105879404150784
collection DOAJ
first_indexed 2024-04-11T10:08:49Z
format Article
id doaj.art-d59bfa25bc6e4f84bc90aa6c8faada40
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T10:08:49Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d59bfa25bc6e4f84bc90aa6c8faada402022-12-22T04:30:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomeshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/?tool=EBI
spellingShingle Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
PLoS ONE
title Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_full Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_fullStr Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_full_unstemmed Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_short Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
title_sort correction the cytokine release inhibitory drug crid3 targets asc oligomerisation in the nlrp3 and aim2 inflammasomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/?tool=EBI